Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microwave Radiation Can Kill Breast Cancer Cells

By HospiMedica staff writers
Posted on 03 Jan 2001
In a phase I clinical trial, researchers found that one to three weeks following a single treatment by a new microwave radiation system, advanced breast cancer tumors typically were reduced in size or destroyed by about 50% in eight out of 10 patients. More...
Phase II clinical trials will now be conducted.

In the procedure, two needle probes are used to sense and measure parameters during treatment. The focused microwave radiation does not heat the skin but heats the cancer cells to about 1150 F and kills them. Breast cancer cells have a high water content, around 80%, while healthy breast tissue contains only 20-60%. The new system has the potential to reduce or eliminate the use of conventional radiation. In the phase II trials, more than 100 women will receive microwave thermotherapy to treat cancer cells. The microwave technology has been licensed to Celsion Corp. (Columbia, MD, USA) by the Massachusetts Institute of Technology (Cambridge, MA, USA).

The new technique was invented by Alan J. Fenn, a senior staff member of MIT's Air Defense Technology Division, based on research he had conducted on radar anti-jamming technology to detect missiles from space-borne satellites. "This is an out-patient procedure,” said Dr. Fenn. "Patients treated in the phase I trial went home with only one or two tiny band aids.”



Related Links:
Celsion

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.